Supplementary Material
Supplementary Figure 1. Kaplan-Meier curves of overall survival (OS) (A) and progression-free survival (PFS) (B) for the patients treated with IO-IO or IO-TKI.
Supplementary Figure 2. Kaplan-Meier curves of overall survival (OS) between IO-IO and IO-TKI according to the number of metastatic organs (<3 or ≥3) (A). Forest plot showing results of multivariable-Cox proportional hazards regression model analyses of four-group (IO–IO <3, IO–IO ≥3, IO–TKI <3, IO–TKI ≥3) for OS, adjusted for age, sex, histology, nephrectomy, and IMDC (B).
Supplementary Table 1. Second-line treatments.
Supplementary Table 2. Patient characteristics (less than three metastatic organs).
Supplementary Table 3. Patient characteristics (three or more metastatic organs).
